Literature DB >> 23474304

The combined effects of glutamine and growth hormone on intestinal anastomosis in the rat intra-abdominal sepsis model.

Ramazan Donmez1, Durkaya Oren, Gurkan Ozturk, Abdullah Kisaoglu, Bunyami Ozogul, Sabri Selcuk Atamanalp.   

Abstract

AIM: Intestinal anastomoses are always risky in patients who develop intra-abdominal sepsis. In this study, the effects of combined glutamine and growth hormone (GH) on healing of intestinal anastomosis following intestinal repair in the rat intra-abdominal sepsis was induced.
MATERIAL AND METHODS: Forty Sprague Dawley Albino rats at 10 weeks weighing between 180 and 240 g were included in the study. All the animals were divided into five groups comprising eight rats each. In the control group, no treatment was given in addition to the routine oral nutrition before and after surgery. In the other groups, following surgery, oral glutamine was given at a dose of 1 mg/kg/d in the glutamine group, subcutaneous GH was given at a dose of 1 mg/kg/d in the GH group, and combined glutamine and GH were administered at the same doses in the glutamine + GH group. In rats, a clinical model mimicking intestinal fistula was generated and fistula repair was performed, and the bursting pressure of the repair area and tissue hydroxyproline level of the repair area were calculated.
RESULTS: Compared with the control group, glutamine, GH, and combined groups displayed significantly higher mean bursting pressures and tissue hydroxyproline levels.
CONCLUSION: In order to decrease the risks originating from impaired mechanisms due to intra-abdominal sepsis, and to make anastomosis safer, combined use of glutamine and GH increases the bursting pressure of anastomosis. While the use of either of these two substances alone is effective, combined use makes this effect more prominent.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23474304     DOI: 10.1016/j.jss.2012.08.033

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Effect of Preoperative Administration of Oral Arginine and Glutamine in Patients with Enterocutaneous Fistula Submitted to Definitive Surgery: a Prospective Randomized Trial.

Authors:  Jose L Martinez; Ilka Bosco-Garate; Luis Manuel Souza-Gallardo; José D Méndez; Marco A Juárez-Oropeza; Ruben Román-Ramos; Eduardo Ferat-Osorio
Journal:  J Gastrointest Surg       Date:  2019-02-01       Impact factor: 3.452

2.  Glutamine with probiotics attenuates intestinal inflammation and oxidative stress in a rat burn injury model through altered iNOS gene aberrant methylation.

Authors:  Zhen-Yu Gong; Zhi-Qiang Yuan; Zhi-Wei Dong; Yi-Zhi Peng
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  Ischemic or toxic injury: A challenging diagnosis and treatment of drug-induced stenosis of the sigmoid colon.

Authors:  Zong-Ming Zhang; Xiang-Chun Lin; Li Ma; An-Qin Jin; Fang-Cai Lin; Zhuo Liu; Li-Min Liu; Chong Zhang; Na Zhang; Li-Juan Huo; Xue-Liang Jiang; Feng Kang; Hong-Jun Qin; Qiu-Yang Li; Hong-Wei Yu; Hai Deng; Ming-Wen Zhu; Zi-Xu Liu; Bai-Jiang Wan; Hai-Yan Yang; Jia-Hong Liao; Xu Luo; You-Wei Li; Wen-Ping Wei; Meng-Meng Song; Yue Zhao; Xue-Ying Shi; Zhao-Hui Lu
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

Review 4.  Influence of Growth Hormone and Glutamine on Intestinal Stem Cells: A Narrative Review.

Authors:  Yun Chen; Ya-Hui Tsai; Bor-Jiun Tseng; Sheng-Hong Tseng
Journal:  Nutrients       Date:  2019-08-17       Impact factor: 5.717

5.  Topical Effect of Glutamine for Colorectal Anastomosis.

Authors:  Jong-Woo Kim
Journal:  Ann Coloproctol       Date:  2015-12-31

6.  Effects of a Glutamine Enema on Anastomotic Healing in an Animal Colon Anastomosis Model.

Authors:  Mani Habibi; Osman Zekai Oner; Mehmet Tahir Oruc; Nurullah Bulbuller; Sebahat Ozdem; Sukru Ozdemir; Arsenal Sezgin Alikanooglu; Rojbin Karakoyun; Ugur Dogan; Ayper Ongen; Umit Koc
Journal:  Ann Coloproctol       Date:  2015-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.